Navigation Links
Arno Therapeutics Appoints William F. Hamilton to Board of Directors
Date:10/30/2008

ties and expertise in technology development and innovation. Bill's insight into the complexities of biotechnology innovation and development will be invaluable in helping us achieve our strategic goals."

About Arno Therapeutics

Arno Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. Arno's lead compound is AR-67, a novel third-generation camptothecin analogue in Phase I studies in patients with advanced solid tumors that has demonstrated high potency and significantly improved pharmacokinetic properties when compared with marketed second-generation products in its class. Arno is also developing two pre-clinical compounds. AR-12 is a potential first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway undergoing IND-enabling studies. AR-42 is an orally available, targeted inhibitor of the Pan-DAC and Akt pathways also undergoing IND-enabling studies. Arno is actively pursuing additional compounds to expand its portfolio. For more information on Arno please visit http://www.arnothera.com.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, outlook, milestones, the success of Arno's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Arno cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
2. Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program
3. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
4. Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrate Superior Profile of S*BIOs Novel Anti-Cancer Drug SB939
5. Synvista Therapeutics Appoints William Federici to its Board of Directors
6. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
7. Cell Therapeutics Regains Compliance with NASDAQs Minimum Bid Price Requirement
8. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
9. Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
10. Afid Therapeutics Inc.s New Anticoagulant Heparin Replacement Passes in Vivo Test
11. Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... 28, 2015 For those people who ... the Mesothelioma Applied Research Foundation (Meso Foundation) ... March 3, starting at 9:30 AM. , The live ... The broadcast can be accessed through any browser on ... , The Symposium is a unique event that covers ...
(Date:2/28/2015)... India Network Foundation, a US based ... for visitors coming to the United States for the ... the United States are suffering from one or two ... diseases are so common among the elderly population that ... There were 66.8 million cases of diabetes in India ...
(Date:2/28/2015)... ON (PRWEB) February 28, 2015 The ... to announce that they have officially relaunched their website. ... more user-friendly, but it contains a new section about ... access to read the full biographies of each Friedman ... portion of the website was designed to provide our ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Plugin creators ... TransFold Volume 2. A fully customizable transition ... “TransFold Volume 2 gives users total control over 30 ... Austin, CEO of Pixel Film Studios. “TransFold Volume 2 ... editor.” , TransFold Volume 2 from Pixel Film Studios ...
(Date:2/27/2015)... 2015 Hispanics develop alcoholic liver disease ... and 12 years earlier than Whites/Caucasians or African Americans, ... System. , While previous research indicated that Hispanics tend ... new study -- published online in the journal Alcoholism: ... the first to pinpoint racial and ethnic disparities in ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2
... Martek Biosciences,(Nasdaq: MATK ) announced today ... for brain, eye and heart health, is now ... from Sunkist licensing,partner, Maverick Brands. Sunkist Naturals Glorious ... produce case in supermarkets across the,country., "The ...
... 6 The national Tourette,Syndrome Association, Inc. (TSA), is ... Representatives approving The Mental Health Parity,Act by a vote ... Health,and Addiction Equity Act (H.R. 1424), the Mental Health ... health insurance packages equal,to the coverage in the plans ...
... Base for MEDIHONEY(TM) Dressings Continues To Grow, ... Bulletin Board: DSCI), a provider of advanced wound ... clinical usage of its,newly released MEDIHONEY Wound & ... presentation at the upcoming annual Symposium on,Advanced Wound ...
... 6 In testimony before a,joint session of the ... John Rowan both praised and damned Congress for actions,taken ... enacted, could make a,huge difference in the lives of ... for the significant increases in,appropriations for veterans health care ...
... dart into the bakery when you spy chocolate- frosted donuts ... As you lick the frosting off your fingers, don,t blame ... University,s Feinberg School of Medicine reveals how hunger works in ... lunge for the sweet fried dough. , Krispy ...
... Letter asks Senate Budget Leaders to Reject Oxygen ... Reform Much More Difficult,to Achieve, Letter Draws ... March 6 The Council for Quality,Respiratory Care ... home oxygen,therapy providers and manufacturers who provide care ...
Cached Medicine News:Health News:Sunkist Naturals Glorious Greens Smoothie Features Martek's life'sDHA 2Health News:Sunkist Naturals Glorious Greens Smoothie Features Martek's life'sDHA 3Health News:Tourette Syndrome Association Celebrates the House Passage of LONG-AWAITED Mental Health Parity Legislation 2Health News:Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference 2Health News:Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference 3Health News:VVA Calls for $5 Billion More for Health Care and Better Outreach 2Health News:Your brain on Krispy Kremes 2Health News:Home Oxygen Community Applauds Senator George Voinovich for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicare's Home Oxygen Benefit 2
(Date:2/27/2015)... and HOUSTON, TX , Feb. 27, ... (TSX-V: EPI) and Bloom Burton & Co. Ltd. ("Bloom ... contractual lock-up (the "Lock-Up") 2,353,130 common shares of the ... originally subject to the Lock-Up. Of the Common Shares ... trading immediately upon release from the Lock-Up while the ...
(Date:2/27/2015)... 2015  In recognition of Rare Disease Day and ... bleeding disorders community, CSL Behring announced today ... of protein therapies to the World Federation of Hemophilia ... has worked to improve the lives of people with ... the WFH,s Global Alliance for Progress (GAP) Program aimed ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... manufactures and markets innovative proprietary products to treat voiding ... 27th Annual ROTH Conference on Tuesday, March 10, 2015. ... Brett Reynolds , Chief Financial Officer, will present at ... on one at the conference at the Ritz Carlton ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... DALLAS, Aug. 3 ACCESS PHARMACEUTICALS, INC. ... update today on its clinical development strategy for ProLindac , ... be active in many solid tumors in human clinical studies. Access has ... dose levels and regimens of ProLindac monotherapy in cancer patients, provide additional data ...
... Grammy-Award winning artist and long-time (PRODUCT)RED supporter John Legend ... for his August 13th, 2009 concert at Madison Square Garden in ... Gap stores in the New York tri-state area will include a ... reserved RED(ZONE) section for John Legend,s MSG show. Even better, with ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 3Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 2John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 3
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
Medicine Products: